Advanced Drug Delivery Systems Market Analysis By Type(Oral, Inhalation, Carrier, Injection, Targeted), By Product Type(Nanocarriers, Micro Needle Patch, Hydrogel, Drug Eluting Lens), By End User(Hospitals, Specialized clinics) & Forecast 2024-2035
- PUBLISHED ON
- 9/1/2022
- NO OF PAGES
- 265
- CATEGORY
- Healthcare & Life Sciences
The global advanced drug delivery systems market size was valued at USD 52.28 billion in 2021 and is projected to reach up to USD 145.0 billion in 2028, exhibiting a CAGR of 16.1% in the forecast period.
The increase in the number of the chronic diseases within the geriatric population of the developing similarly because the developed nations are driving the market growth. For instance, the number of patients with cardiovascular diseases (CVDs) approximately doubled from 271 million in 1990 to 523 million in 2019. The rising prevalence of such diseases can be accredited to the adoption of unhealthy and sedentary lifestyles, rising geriatric population, excessive consumption of saturated trans-fat food, tobacco consumption, physical inactivity, obesity, and family history of CVDs. As per a study, in 2019, around 28.2 million adults in the US were detected with heart diseases. The market is growing in a steady pace and there is a rise in the healthcare expenditure in the emerging nations.
The growth in healthcare expenditure has been accredited to the increased consumer awareness of health, improved government and corporate initiatives, and venture by public-private sector companies to accomplish consumer demands in developing nations. As a result, all of these factors provide opportunities for investments in the research and innovation process and the development of advanced drug delivery solutions for enriched drug efficacy and protected therapy for existing drugs as well as upcoming novel molecular entities, which accelerates the market growth. Favourable compensation policies and increase text editor on health care facilities by the customers has boosted the market. The prevailing of rigorous government laws that recall several medicine happens to be one among the main challenges for the expansion of the market. within the recent years there has been a rise within the variety of failing medicine and it cell hamper the market growth within the coming years.
The advanced drug delivery market had a positive impact throughout the COVID-19 pandemic. So as to treat the affected patients across the world the hospitals in addition to the clinics was reorganised as per the requirement. For instance, in June 2020, the Chalmers University of Technology in Sweden, the University of Gothenburg, and AstraZeneca initiated new pivotal research including several favourable concepts to examine a nasal spray mRNA vaccine against COVID-19. However, because of limited movement the transportation and producing of assorted provides needed for the hospital were affected to a good extent.
Similarly, in April 2020, Bioavanta-Bosti started a 48-hour manufacturing process using its Novochizol chitosan polysaccharide nanotechnology to condense APIs or biologics for localized delivery and sustained release intra-pulmonary drug delivery preparations, which are suitable for handling COVID-19 patients. Continuous analysis for the treatment and vaccines for combating the pandemic created a positive and higher demand for the advanced drug delivery market.
Type Insights
On the basis of the type, the oral drug delivery system market is predicted to possess the largest market share throughout the forecast period. The oral drug delivery phase is predicted to dominate the market within the forthcoming years because of a rise within the quality of this delivery system. within the recent years there has been a rise within the quality of this technique creative person most well-liked by the patients in addition because the physicians.
The oral drug delivery method is the most common and chosen drug administration route by the physicians and the patients. The demand for this route of administration mostly relies in the convenience of intake and the availability of a broad window of the therapeutic index, which, in turn, lowers the probability of toxicity and side effects. The augmented pace of advanced oral drug delivery system development is raised by an increasing market of controlled release formulations and new launches in key therapeutic areas such as the metabolic, central nervous system and cardiovascular, and respiratory diseases. For instance, in 2020, Progenity Inc. stated positive preliminary preclinical data about the performance of its oral drug delivery system (DDS), the DDS capsule that uses a proprietary autonomous localization technology intended to identify the ileal/ileocecal region of the GI tract. This expertise is based on anatomy and is intended to resist inconsistency in physiological conditions like motility, pH, and bacteria. The launch of such products will provide growth opportunities for the segment in the near future.
Product Type Insights
On the basis of product type, the nanocarrier phase is predicted to grow well throughout the forecast. As this kind of drug are often administered within the oral means or it can even be used for inhalation in addition as application. it's extraordinarily helpful for the targeted delivery of the medicine. the utilization of a nanocarrier helps in rising the potency of the intake of a drug because it in an exceedingly position to focus on the positioning of the affected space in lot of economical means. It conjointly helps Cindy absorption of the medicine in a very fascinating means particularly for the medicine that are poorly soluble.
In the recent years, constant analysis on developing nanocarrier has accrued the quantity of the nanocarrier. it's wide used for the patients suffering with cancer. the utilization of nanocarrier for the drug delivery within the patients suffering with cancer has proved to be extraordinarily economical in delivering the medicine to the desired website. It provides higher therapeutic outputs. so as to treat differing types of tumors an oversized variety of nanocarrier product are approved by the restrictive bodies.
End User Insights
On the basis of the end user, the hospital segment will lead the market during the forecast period. The hospital segment is anticipated to grow at a significant CAGR during the forecast period. As it has been an increase in the use of advanced drug delivery for treating different orthopaedic conditions, oncology and neurology the market is anticipated to grow. The convenience of advanced infrastructure add professionals with great expertise in this field will drive the market during the forecast period. The increased number of chronic diseases in the elderly population is anticipated to grow in the coming years and it will drive the market growth.
Region Insights
The North American region is anticipated to rule the market during the forecast period. The convenience of advanced health care facilities and a growing popularity of the advanced drug delivery in the region will boost the market growth during the forecast period. The region has dominated the market in the past due to the availability of various solutions. Since there has been a great demand for treating numerous chronic diseases with the use of the drugs in the self- administered form the market is predicted to grow. The use of injectable is expected to grow during the forecast period.
Moreover, the joint initiatives taken by the non-profit organizations, market players, and government agencies are also forcing the growth of the market in the region. For example, in March 2022, TFF Pharmaceuticals, Inc. entered into a Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), which is a part of the United States Army Medical Research and Development Command and the United States Army's foremost institution and facility for protective measures against biological warfare, and the Geneva Foundation that improves innovative medical research within the United States military. Such joint initiatives are also estimated to propel the growth of the market. Thus, owing to the aforementioned factors, the North American region is projected to show growth over the forecast period.
Key Companies Insights
Key players are focusing on their technological partnerships, collaborations, and merger & acquisitions strategies to gain a competitive edge and expand their product portfolio & business footprint. The ongoing Covid-19 pandemic hampered the systems across the globe and drove market players to innovate products for several opportunities.
Some of the key players operating in the global advanced drug delivery systems market include:
• Baxter
• Boston Scientific Corporation
• AbbVie Inc.
• Becton, Dickinson and Company
• Kindeva Drug Delivery L.P
• Bausch Health Companies Inc.
• Novo Nordisk A/S
• Ocular Therapeutix, Inc.
• 3M
• Raphas Co., Ltd.
• GALDERMA
• NanoPass
• Altaris
• MicropointTechnologies
• Takeda Pharmaceutical Company Limited
• Other players
Some of the Recent Developments:
• In March 2022, Corium, Inc. received United States Food and Drug Administration (FDA) approval for Corium's ADLARITY (donepezil transdermal system) for the treatment of patients with mild, moderate, or severe dementia of the Alzheimer's type.
• In March 2022, the United States Food and Drug Administration approved the first generic of Symbicort Inhalation Aerosol for the treatment of two common pulmonary health conditions: asthma in patients of six years of age and older, and chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
• In February 2019, Sandoz, a Novartis division, received European Commission authorization in Spain for its adalimumab biosimilar, HYRIMOZ, for subcutaneous injection in a syringe or a prefilled pen.
Segments
By Type
• Oral
• Inhalation
• Carrier
• Injection
• Targeted
• Others
By Product Type
• Nanocarriers
• Micro Needle Patch
• Hydrogel
• Drug Eluting Lens
By End User
• Hospitals
• Specialized clinics
• Others
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Historic Year: 2016-2022
Forecast: 2024-2035
1 Advanced Drug Delivery Systems Market Definition and Overview
1.1 Objectives of the Study
1.2 Overview of Advanced Drug Delivery Systems
1.3 Advanced Drug Delivery Systems Market Scope and Market Size Estimation
1.4 Market Segmentation
1.4.1 Types of Advanced Drug Delivery Systems
1.4.2 Applications of Advanced Drug Delivery Systems
1.5 Market Exchange Rate
2 Research Method and Logic
2.1 Methodology
2.2 Research Data Source
3 Market Competition Analysis
3.1 Boston Scientific Corporation Market Performance Analysis
3.1.1 Boston Scientific Corporation Basic Information
3.1.2 Product and Service Analysis
3.1.3 Strategies for Company to Deal with the Impact of COVID-19
3.1.4 Boston Scientific Corporation Sales, Value, Price, Gross Margin 2016-2021
3.2 Novartis AG Market Performance Analysis
3.2.1 Novartis AG Basic Information
3.2.2 Product and Service Analysis
3.2.3 Strategies for Company to Deal with the Impact of COVID-19
3.2.4 Novartis AG Sales, Value, Price, Gross Margin 2016-2021
3.3 Bayer Healthcare Market Performance Analysis
3.3.1 Bayer Healthcare Basic Information
3.3.2 Product and Service Analysis
3.3.3 Strategies for Company to Deal with the Impact of COVID-19
3.3.4 Bayer Healthcare Sales, Value, Price, Gross Margin 2016-2021
3.4 Baxter International Market Performance Analysis
3.4.1 Baxter International Basic Information
3.4.2 Product and Service Analysis
3.4.3 Strategies for Company to Deal with the Impact of COVID-19
3.4.4 Baxter International Sales, Value, Price, Gross Margin 2016-2021
3.5 Amgen Inc. Market Performance Analysis
3.5.1 Amgen Inc. Basic Information
3.5.2 Product and Service Analysis
3.5.3 Strategies for Company to Deal with the Impact of COVID-19
3.5.4 Amgen Inc. Sales, Value, Price, Gross Margin 2016-2021
3.6 Abbott Laboratories Market Performance Analysis
3.6.1 Abbott Laboratories Basic Information
3.6.2 Product and Service Analysis
3.6.3 Strategies for Company to Deal with the Impact of COVID-19
3.6.4 Abbott Laboratories Sales, Value, Price, Gross Margin 2016-2021
3.7 3M Market Performance Analysis
3.7.1 3M Basic Information
3.7.2 Product and Service Analysis
3.7.3 Strategies for Company to Deal with the Impact of COVID-19
3.7.4 3M Sales, Value, Price, Gross Margin 2016-2021
3.8 Astrazeneca Market Performance Analysis
3.8.1 Astrazeneca Basic Information
3.8.2 Product and Service Analysis
3.8.3 Strategies for Company to Deal with the Impact of COVID-19
3.8.4 Astrazeneca Sales, Value, Price, Gross Margin 2016-2021
3.9 Glaxosmithkline PLC Market Performance Analysis
3.9.1 Glaxosmithkline PLC Basic Information
3.9.2 Product and Service Analysis
3.9.3 Strategies for Company to Deal with the Impact of COVID-19
3.9.4 Glaxosmithkline PLC Sales, Value, Price, Gross Margin 2016-2021
3.10 Merck & Co. Market Performance Analysis
3.10.1 Merck & Co. Basic Information
3.10.2 Product and Service Analysis
3.10.3 Strategies for Company to Deal with the Impact of COVID-19
3.10.4 Merck & Co. Sales, Value, Price, Gross Margin 2016-2021
4 Market Segment by Type, Historical Data and Market Forecasts
4.1 Global Advanced Drug Delivery Systems Production and Value by Type
4.1.1 Global Advanced Drug Delivery Systems Production by Type 2016-2021
4.1.2 Global Advanced Drug Delivery Systems Market Value by Type 2016-2021
4.2 Global Advanced Drug Delivery Systems Market Production, Value and Growth Rate by Type 2016-2021
4.2.1 Oral Drug Delivery System Market Production, Value and Growth Rate
4.2.2 Injection-based Drug Delivery System Market Production, Value and Growth Rate
4.2.3 Inhalation/Pulmonary Drug Delivery System Market Production, Value and Growth Rate
4.2.4 Transdermal Drug Delivery System Market Production, Value and Growth Rate
4.2.5 Trans mucosal Drug Delivery System Market Production, Value and Growth Rate
4.2.6 Carrier-based Drug Delivery System Market Production, Value and Growth Rate
4.2.7 Other Types Market Production, Value and Growth Rate
4.3 Global Advanced Drug Delivery Systems Production and Value Forecast by Type
4.3.1 Global Advanced Drug Delivery Systems Production Forecast by Type 2021-2026
4.3.2 Global Advanced Drug Delivery Systems Market Value Forecast by Type 2021-2026
4.4 Global Advanced Drug Delivery Systems Market Production, Value and Growth Rate by Type Forecast 2021-2026
4.4.1 Oral Drug Delivery System Market Production, Value and Growth Rate Forecast
4.4.2 Injection-based Drug Delivery System Market Production, Value and Growth Rate Forecast
4.4.3 Inhalation/Pulmonary Drug Delivery System Market Production, Value and Growth Rate Forecast
4.4.4 Transdermal Drug Delivery System Market Production, Value and Growth Rate Forecast
4.4.5 Trans mucosal Drug Delivery System Market Production, Value and Growth Rate Forecast
4.4.6 Carrier-based Drug Delivery System Market Production, Value and Growth Rate Forecast
4.4.7 Other Types Market Production, Value and Growth Rate Forecast
5 Market Segment by Application, Historical Data and Market Forecasts
5.1 Global Advanced Drug Delivery Systems Consumption and Value by Application
5.1.1 Global Advanced Drug Delivery Systems Consumption by Application 2016-2021
5.1.2 Global Advanced Drug Delivery Systems Market Value by Application 2016-2021
5.2 Global Advanced Drug Delivery Systems Market Consumption, Value and Growth Rate by Application 2016-2021
5.2.1 Cardiovascular Diseases Market Consumption, Value and Growth Rate
5.2.2 Oncology Market Consumption, Value and Growth Rate
5.2.3 Urology Market Consumption, Value and Growth Rate
5.2.4 Diabetes Market Consumption, Value and Growth Rate
5.2.5 CNS Market Consumption, Value and Growth Rate
5.2.6 Ophthalmology Market Consumption, Value and Growth Rate
5.2.7 Inflammatory Diseases Market Consumption, Value and Growth Rate
5.2.8 Infections Market Consumption, Value and Growth Rate
5.2.9 Other Applications Market Consumption, Value and Growth Rate
5.3 Global Advanced Drug Delivery Systems Consumption and Value Forecast by Application
5.3.1 Global Advanced Drug Delivery Systems Consumption Forecast by Application 2021-2026
5.3.2 Global Advanced Drug Delivery Systems Market Value Forecast by Application 2021-2026
5.4 Global Advanced Drug Delivery Systems Market Consumption, Value and Growth Rate by Application Forecast 2021-2026
5.4.1 Cardiovascular Diseases Market Consumption, Value and Growth Rate Forecast
5.4.2 Oncology Market Consumption, Value and Growth Rate Forecast
5.4.3 Urology Market Consumption, Value and Growth Rate Forecast
5.4.4 Diabetes Market Consumption, Value and Growth Rate Forecast
5.4.5 CNS Market Consumption, Value and Growth Rate Forecast
5.4.6 Ophthalmology Market Consumption, Value and Growth Rate Forecast
5.4.7 Inflammatory Diseases Market Consumption, Value and Growth Rate Forecast
5.4.8 Infections Market Consumption, Value and Growth Rate Forecast
5.4.9 Other Applications Market Consumption, Value and Growth Rate Forecast
6 Global Advanced Drug Delivery Systems by Region, Historical Data and Market Forecasts
6.1 Global Advanced Drug Delivery Systems Sales by Region 2016-2021
6.2 Global Advanced Drug Delivery Systems Market Value by Region 2016-2021
6.3 Global Advanced Drug Delivery Systems Market Sales, Value and Growth Rate by Region 2016-2021
6.3.1 North America
6.3.2 Europe
6.3.3 Asia Pacific
6.3.4 South America
6.3.5 Middle East and Africa
6.4 Global Advanced Drug Delivery Systems Sales Forecast by Region 2021-2026
6.5 Global Advanced Drug Delivery Systems Market Value Forecast by Region 2021-2026
6.6 Global Advanced Drug Delivery Systems Market Sales, Value and Growth Rate Forecast by Region 2021-2026
6.6.1 North America
6.6.2 Europe
6.6.3 Asia Pacific
6.6.4 South America
6.6.5 Middle East and Africa
7 United State Market Size Analysis 2016-2026
7.1 United State Advanced Drug Delivery Systems Value and Market Growth 2016-2021
7.2 United State Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
7.3 United State Advanced Drug Delivery Systems Market Value Forecast 2021-2026
8 Canada Market Size Analysis 2016-2026
8.1 Canada Advanced Drug Delivery Systems Value and Market Growth 2016-2021
8.2 Canada Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
8.3 Canada Advanced Drug Delivery Systems Market Value Forecast 2021-2026
9 Germany Market Size Analysis 2016-2026
9.1 Germany Advanced Drug Delivery Systems Value and Market Growth 2016-2021
9.2 Germany Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
9.3 Germany Advanced Drug Delivery Systems Market Value Forecast 2021-2026
10 UK Market Size Analysis 2016-2026
10.1 UK Advanced Drug Delivery Systems Value and Market Growth 2016-2021
10.2 UK Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
10.3 UK Advanced Drug Delivery Systems Market Value Forecast 2021-2026
11 France Market Size Analysis 2016-2026
11.1 France Advanced Drug Delivery Systems Value and Market Growth 2016-2021
11.2 France Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
11.3 France Advanced Drug Delivery Systems Market Value Forecast 2021-2026
12 Italy Market Size Analysis 2016-2026
12.1 Italy Advanced Drug Delivery Systems Value and Market Growth 2016-2021
12.2 Italy Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
12.3 Italy Advanced Drug Delivery Systems Market Value Forecast 2021-2026
13 Spain Market Size Analysis 2016-2026
13.1 Spain Advanced Drug Delivery Systems Value and Market Growth 2016-2021
13.2 Spain Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
13.3 Spain Advanced Drug Delivery Systems Market Value Forecast 2021-2026
14 Russia Market Size Analysis 2016-2026
14.1 Russia Advanced Drug Delivery Systems Value and Market Growth 2016-2021
14.2 Russia Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
14.3 Russia Advanced Drug Delivery Systems Market Value Forecast 2021-2026
15 China Market Size Analysis 2016-2026
15.1 China Advanced Drug Delivery Systems Value and Market Growth 2016-2021
15.2 China Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
15.3 China Advanced Drug Delivery Systems Market Value Forecast 2021-2026
16 Japan Market Size Analysis 2016-2026
16.1 Japan Advanced Drug Delivery Systems Value and Market Growth 2016-2021
16.2 Japan Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
16.3 Japan Advanced Drug Delivery Systems Market Value Forecast 2021-2026
17 South Korea Market Size Analysis 2016-2026
17.1 South Korea Advanced Drug Delivery Systems Value and Market Growth 2016-2021
17.2 South Korea Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
17.3 South Korea Advanced Drug Delivery Systems Market Value Forecast 2021-2026
18 Australia Market Size Analysis 2016-2026
18.1 Australia Advanced Drug Delivery Systems Value and Market Growth 2016-2021
18.2 Australia Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
18.3 Australia Advanced Drug Delivery Systems Market Value Forecast 2021-2026
19 Thailand Market Size Analysis 2016-2026
19.1 Thailand Advanced Drug Delivery Systems Value and Market Growth 2016-2021
19.2 Thailand Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
19.3 Thailand Advanced Drug Delivery Systems Market Value Forecast 2021-2026
20 Brazil Market Size Analysis 2016-2026
20.1 Brazil Advanced Drug Delivery Systems Value and Market Growth 2016-2021
20.2 Brazil Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
20.3 Brazil Advanced Drug Delivery Systems Market Value Forecast 2021-2026
21 Argentina Market Size Analysis 2016-2026
21.1 Argentina Advanced Drug Delivery Systems Value and Market Growth 2016-2021
21.2 Argentina Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
21.3 Argentina Advanced Drug Delivery Systems Market Value Forecast 2021-2026
22 Chile Market Size Analysis 2016-2026
22.1 Chile Advanced Drug Delivery Systems Value and Market Growth 2016-2021
22.2 Chile Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
22.3 Chile Advanced Drug Delivery Systems Market Value Forecast 2021-2026
23 South Africa Market Size Analysis 2016-2026
23.1 South Africa Advanced Drug Delivery Systems Value and Market Growth 2016-2021
23.2 South Africa Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
23.3 South Africa Advanced Drug Delivery Systems Market Value Forecast 2021-2026
24 Egypt Market Size Analysis 2016-2026
24.1 Egypt Advanced Drug Delivery Systems Value and Market Growth 2016-2021
24.2 Egypt Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
24.3 Egypt Advanced Drug Delivery Systems Market Value Forecast 2021-2026
25 UAE Market Size Analysis 2016-2026
25.1 UAE Advanced Drug Delivery Systems Value and Market Growth 2016-2021
25.2 UAE Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
25.3 UAE Advanced Drug Delivery Systems Market Value Forecast 2021-2026
26 Saudi Arabia Market Size Analysis 2016-2026
26.1 Saudi Arabia Advanced Drug Delivery Systems Value and Market Growth 2016-2021
26.2 Saudi Arabia Advanced Drug Delivery Systems Sales and Market Growth 2016-2021
26.3 Saudi Arabia Advanced Drug Delivery Systems Market Value Forecast 2021-2026
27 Market Dynamic Analysis and Development Suggestions
27.1 Market Drivers
27.2 Market Development Constraints
27.3 PEST Analysis
27.3.1 Political Factors
27.3.2 Economic Factors
27.3.3 Social Factors
27.3.4 Technological Factors
27.4 Industry Trends Under COVID-19
27.4.1 Risk Assessment on COVID-19
27.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
27.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
27.5 Market Entry Strategy Analysis
27.5.1 Market Definition
27.5.2 Client
27.5.3 Distribution Model
27.5.4 Product Messaging and Positioning
27.5.5 Price
27.6 Advice on Entering the Market
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI